We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+5.65%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.31B
AUM Growth
+$72.1M
Cap. Flow
-$212M
Cap. Flow %
-6.41%
Top 10 Hldgs %
31.06%
Holding
111
New
31
Increased
21
Reduced
21
Closed
33

Top Buys

Rank Stock Value
1
AET
Aetna Inc
AET
+$92.4M
2
BIIB icon
Biogen
BIIB
+$88.4M
3
BAX icon
Baxter International
BAX
+$59.5M
4
DISH
DISH Network Corp.
DISH
+$58.6M
5
META icon
Meta Platforms (Facebook)
META
+$53.6M

Top Sells

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$110M
2
AAPL icon
Apple
AAPL
+$94.8M
3
BMY icon
Bristol-Myers Squibb
BMY
+$94M
4
LRCX icon
Lam Research
LRCX
+$90.7M
5
AGN
Allergan plc
AGN
+$84.2M

Sector Composition

Rank Sector Weight
1 Healthcare 38.8%
2 Technology 9.31%
3 Communication Services 4.67%
4 Energy 3.99%
5 Financials 3.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THC icon
51
Tenet Healthcare
THC
$20.1B
$19.1M 0.58%
+691,461
New +$20.4M
RICE
52
DELISTED
Rice Energy Inc.
RICE
$19.1M 0.58%
+865,063
New +$16.2M
V icon
53
Visa
V
$677B
$17.5M 0.53%
+235,872
New +$18.5M
GBT
54
DELISTED
Global Blood Therapeutics, Inc.
GBT
$17.1M 0.52%
1,028,867
+285,881
+38% +$5.77M
ZLTQ
55
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$16.5M 0.5%
604,342
-293,787
-33% -$8.26M
VIPS icon
56
Vipshop
VIPS
$6.84B
$16.3M 0.49%
+1,460,749
New +$17.9M
MOH icon
57
Molina Healthcare
MOH
$10.3B
$15.7M 0.47%
+315,479
New +$16.9M
KITE
58
DELISTED
Kite Pharma, Inc.
KITE
$15.6M 0.47%
311,765
-2,000
-0.6% -$98.3K
GWPH
59
PUT
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$15.5M 0.47%
+169,000
New +$14.2M
VYGR icon
60
Voyager Therapeutics
VYGR
$187M
$14.7M 0.44%
1,335,671
+442,130
+49% +$5.41M
SLCA
61
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$13.2M 0.4%
+382,341
New +$10.6M
HDP
62
DELISTED
Hortonworks, Inc.
HDP
$12.5M 0.38%
1,172,433
-183,537
-14% -$2.07M
AAPL icon
63
Apple
AAPL
$4.89T
$12.5M 0.38%
522,640
-3,816,372
-88% -$94.8M
LIVN icon
64
LivaNova
LIVN
$4.3B
$12.3M 0.37%
+244,851
New +$12.4M
VRTX icon
65
Vertex Pharmaceuticals
VRTX
$121B
$11.7M 0.35%
+135,487
New +$11.7M
MYOK
66
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$10.4M 0.31%
838,810
+74,178
+10% +$927K
SPNC
67
DELISTED
Spectranetics Corp
SPNC
$4.83M 0.15%
258,019
-35,561
-12% -$626K
KURA icon
68
Kura Oncology
KURA
$922M
$4.53M 0.14%
1,671,164
+129,212
+8% +$402K
DMTX
69
DELISTED
Dimension Therapeutics, Inc
DMTX
$4M 0.12%
666,070
-59,099
-8% -$450K
PEN icon
70
Penumbra
PEN
$12.5B
$2.27M 0.07%
38,186
-24,859
-39% -$1.34M
ARA
71
DELISTED
American Renal Associates Holdings, Inc
ARA
$1.52M 0.05%
+52,427
New +$1.46M
INVA icon
72
Innoviva
INVA
$1.58B
$1.41M 0.04%
133,897
-1,352,317
-91% -$16M
INSY
73
PUT
DELISTED
Insys Therapeutics, Inc.
INSY
$672K 0.02%
+51,900
New +$756K
ABBV icon
74
CALL
AbbVie
ABBV
$458B
– –
-930,600
Closed -$53.2M
ACHC icon
75
Acadia Healthcare
ACHC
$3.17B
– –
-130,817
Closed -$7.21M
1 2
3
4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q2 2016 Portfolio in Review

As of Q2 2016, PFM Health Sciences held 111 positions worth $3.31B, up 2.2% from $3.24B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

PFM Health Sciences withdrew a net $212M in Q2 2016, closing 33 positions and reducing 21 holdings. Its most notable exit was Lam Research, an estimated $90.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 45% a quarter earlier, followed by Technology and Communication Services.

Against the trend, PFM Health Sciences opened a new position in Biogen worth $81.1M.

  • PFM Health Sciences's largest Q2 2016 buy was Biogen: 335,290 shares worth $81.1M.
  • PFM Health Sciences added most to Aetna Inc in Q2 2016, an estimated $92.4M increase.
  • PFM Health Sciences's biggest Q2 2016 reduction was HCA Healthcare, cutting an estimated $110M.
  • PFM Health Sciences fully exited Lam Research in Q2 2016, selling an estimated $90.7M.
  • PFM Health Sciences's ten largest holdings make up 31% of its $3.31B portfolio in Q2 2016.
  • PFM Health Sciences opened 31 new positions and closed 33 in Q2 2016.
  • PFM Health Sciences's portfolio value rose 2.2% quarter-over-quarter to $3.31B.

Based on PFM Health Sciences's 13F filing for Q2 2016, filed 15 Aug 2016.